Risperidone Use in Autism Spectrum Disorders: A Retrospective Review of a Clinic-Referred Patient Population
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Risperidone is widely used in children with autism spectrum disorders for behavioral modification. In this study, the authors aimed to (1) describe a clinic-referred sample of patients with an autism spectrum disorder on risperidone, (2) identify differences between the success and nonsuccess groups, and (3) describe our experience with young children (< age 5 years) on risperidone. Eighty patients were initiated on risperidone. Indications included aggression (66%), impulsivity (14%), and stereotypies (4%). Sixty-six percent met criteria for success at 6 months and 53% at 1 year. Sixty-seven percent of the nonsuccess group reported side effects, compared to 47% of the success group. Weight gain was the most common side effect in both groups, followed by somnolence. Somnolence was the most robust predictor of nonsuccess. In our clinic-referred sample, the short-term success rate of risperidone was more than 50%, and side effects limited its use. Although weight gain was common, somnolence more significantly influenced treatment discontinuation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Autism spectrum disorders: Concurrent clinical disorders
Ming, X., Brimacombe, M., Chaaban, J., Zimmerman-Bier, B., & Wagner, G. C. (2008) · Journal of Child Neurology · doi:10.1177/0883073807307102 · Cited by 266
Arnold, L. E., Farmer, C., Kraemer, H. C., Davies, M., Witwer, A., Chuang, S., DiSilvestro, R., McDougle, C. J., McCracken, J., Vitiello, B., et al. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0022 · Cited by 58
Cited by
An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options
Masi, A., DeMayo, M. M., Glozier, N., & Guastella, A. J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0100-y · Cited by 987
(2015) · PubMed · Cited by 65
Lack of effect of risperidone on core autistic symptoms: data from a longitudinal study
Marrus, N., Underwood-Riordan, H., Randall, F., Zhang, Y., & Constantino, J. N. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0055 · Cited by 29
“…retrospective, introducing possible re-call bias, the benefits and side effects reported by parents conform well to what is documented in the literature (Troost et al., 2005; Jesner et al. 2007; Lemmon et al. 2011; McPheeters et al. 2011), supporting the validity of parent report for this purpose.”
Metadata
- Authors
- Lemmon, M. E., Gregas, M., & Jeste, S. S.
- Venue
- Journal of Child Neurology
- Publisher
- SAGE Publications
- Published
- 2010-10-06
- Volume
- 26
- Issue
- 4
- Pages
- 428-432
- ISSN
- 0883-0738 (ISSN-L)
- 1708-8283
- OpenAlex
- W2108625299
- Cited by
- 45
- References
- 3
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risperidone Use in Autism Spectrum Disorders: A Retrospective Review of a Clinic-Referred Patient Population. https://app.cochat.ai/papers/10.1177/0883073810382143
- The paper
- Lemmon, M. E., Gregas, M., & Jeste, S. S. (2011). Risperidone Use in Autism Spectrum Disorders: A Retrospective Review of a Clinic-Referred Patient Population. Journal of Child Neurology. https://doi.org/10.1177/0883073810382143
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.